Skip to main content

SB 480 — Hawaii

RELATING TO HEALTH.

Introduced 2026 session Senate

This page lists STATE bills only. Open States, our source for this data, tracks state legislatures -- it has no visibility into city councils, county commissions or school boards. We don't yet have a free, storable source for local measures; see the About page for why.

Summary

Prohibits drug manufacturers and wholesale distributors from restricting or denying access for pharmacies contracted with 340B covered entities to purchase 340B drugs at a discounted price under the federal 340B Drug Pricing Program. Imposes civil penalties for engaging in unfair or deceptive acts or practices in the conduct of any trade or commerce.

Official abstract, as published by the legislature.

  • SB 480 is a bill in the Hawaii Senate, 2026 session, introduced January 17, 2025.
  • Sponsored by SAN BUENAVENTURA, with 1 cosponsor.
  • Current status: introduced.
  • Most recent action (December 8, 2025): Carried over to 2026 Regular Session.
  • Subjects: 340B Drug Pricing Program, Affordable Health Care, Covered Entities, Department of Health, Discriminatory Practices, Pharmacies.

Contact your legislator about this bill

Bill text & documents

Sponsors

Primary: SAN BUENAVENTURA

Cosponsors (1): Fukunaga

History

  1. Introduced, completed
  2. Passed Senate, in progress
  3. Passed House, not reached yet
  4. Sent to Governor, not reached yet
  5. Signed into law, not reached yet
  1. Senate Passed First Reading.
  2. Senate Introduced. Milestone
  3. Senate Referred to HHS, CPN/JDC.
  4. Senate The committee(s) on HHS has scheduled a public hearing on 02-10-25 1:20PM; Conference Room 225 & Videoconference.
  5. Senate The committee on HHS deferred the measure.
  6. Legislature Carried over to 2026 Regular Session. Latest

Source: Open States. Last checked November 7, 2026. How we keep this accurate ›